In the intricate world of pharmaceutical manufacturing, specific chemical intermediates play pivotal roles in bringing life-saving medications to market. One such critical compound is N-[3-Chloro-4-(3-fluorobenzyloxy)phenyl]-6-iodoquinazolin-4-amine, identified by its CAS number 231278-20-9. This advanced chemical is a cornerstone in the synthesis of Lapatinib, a potent tyrosine kinase inhibitor used in the treatment of certain types of breast cancer. NINGBO INNO PHARMCHEM CO.,LTD. recognizes the paramount importance of reliable sourcing for such vital intermediates to support the global healthcare industry.

The precise molecular structure of N-[3-Chloro-4-(3-fluorobenzyloxy)phenyl]-6-iodoquinazolin-4-amine, with its quinazoline core and specific halogen and ether substitutions, provides the exact chemical scaffolding required for the efficient synthesis of Lapatinib. The purity and quality of this intermediate directly impact the final drug product's efficacy and safety profile. Therefore, pharmaceutical companies and research institutions rely on manufacturers like NINGBO INNO PHARMCHEM CO.,LTD. to supply this chemical with stringent quality control and high purity standards.

The demand for Lapatinib, and consequently for its key intermediates, underscores the need for robust supply chains. Sourcing N-[3-Chloro-4-(3-fluorobenzyloxy)phenyl]-6-iodoquinazolin-4-amine from a trusted supplier ensures that drug development pipelines remain uninterrupted. NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to providing this essential component, facilitating the research and production efforts aimed at combating serious diseases. Our commitment to quality and timely delivery makes us a preferred partner for companies seeking to buy N-[3-Chloro-4-(3-fluorobenzyloxy)phenyl]-6-iodoquinazolin-4-amine.